AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer
Conditions: Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma Interventions: Biological: Cadonilimab; Biological: Ivonescimab; Drug: XELOX; Drug: SOX Sponsors: Harbin Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Gastric (Stomach) Cancer | Gastroenterology | Research